Back to Top Skip to main content

Smallpox (Jynneos)

On September 24, 2019, the U.S. Food and Drug Administration (FDA) approved the first live, non-replicating vaccine for prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection.

While there is currently no vaccine available from the manufacturer for use, the Department of Defense and other government partners are engaged in robust discussions regarding future deployment of this vaccine within the military.

Further information will be provided once available.

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing | Download a PDF Reader or learn more about PDFs.